8-KItem 7.01 · Reg FD Disclosure
Humana Reaffirms 2026 EPS Guidance Ahead of Investor Meetings
Filed with the SEC on · Summarized by InvestorsBot
Humana said it will reaffirm its 2026 guidance of at least $6.52 in GAAP diluted EPS and at least $9.00 in adjusted EPS during investor meetings scheduled from September 1 through September 30, 2026. The company expects no changes to its adjusted EPS outlook but noted that GAAP EPS could change because of ongoing value creation and other strategic initiatives; it will not comment on 2027 Medicare Advantage Star Ratings until CMS releases final data in October.